Neurotoxicity of MAO Metabolites of Catecholamine Neurotransmitters: Role in Neurodegenerative Diseases

By Burke W.J.   Li S.W.   Chung H.D.   Ruggiero D.A.   Kristal B.S.   Johnson E.M.   Lampe P.   Kumar V.B.   Franko M.   Williams E.A.   Zahm D.S.  

Neurotoxicology, Vol. 25, Iss. 1, 2004-01 ,pp. : 101-115

Elsevier

Access to resources Recommend Favorite

Intranasal Lipid Nanoparticles for the Treatment of Neurodegenerative Diseases

By  

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6553-6562

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Roles of Microglial Cells for Neurotoxicity in Clinical Neurodegenerative Diseases and Experimental Animal Models

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 8, Iss. 4, 2009-09 ,pp. : 277-284

Bentham Science Publishers

Access to resources Recommend Favorite

Hydrophobic Plant Antioxidants. Preparation of Nanoparticles and their Application for Prevention of Neurodegenerative Diseases. Review and Experimental Data

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 22, 2014-11 ,pp. : 2520-2528

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticles in the Brain: A Potential Therapeutic System Targeted to an Early Defect Observed in Many Neurodegenerative Diseases

By Gunawardena Shermali  

Pharmaceutical Research, Vol. 30, Iss. 10, 2013-10 ,pp. : 2459-2474

Springer Publishing Company

Access to resources Recommend Favorite